Evidence map›Paper›PMID 27109210›Full record

ArticleNature communications2016

A genetic basis for the variation in the vulnerability of cancer to DNA damage.

Brian D Yard, Drew J Adams, Eui Kyu Chie, Pablo Tamayo, Jessica S Battaglia, Priyanka Gopal, Kevin Rogacki, Bradley E Pearson, James Phillips, Daniel P Raymond and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Differentiation Stage Predicts Radiosensitivity in Mesenchymal-Like Pancreatic Cancer.International journal of radiation oncology, biology, physics · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Imaging genomics of cancer: a bibliometric analysis and review.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Review
  18. Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Brian D YardDepartment of Translational Hematology Oncology Research, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.
Drew J AdamsDepartment of Genetics, Case Western Reserve University, 2109 Adelbert Road/BRB, Cleveland, Ohio 44106, USA.
Eui Kyu ChieDepartment of Translational Hematology Oncology Research, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.
Pablo TamayoBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, USA.ORCID http://orcid.org/0000-0002-9360-4668
Jessica S BattagliaDepartment of Translational Hematology Oncology Research, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.
Priyanka GopalDepartment of Translational Hematology Oncology Research, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.
Kevin RogackiDepartment of Translational Hematology Oncology Research, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.
Bradley E PearsonDepartment of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA.
James PhillipsDepartment of Translational Hematology Oncology Research, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.
Daniel P RaymondDepartment of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Avenue/J4-1, Cleveland, Ohio 44195, USA.
Nathan A PennellDepartment of Hematology and Medical Oncology, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.
Francisco AlmeidaDepartment of Pulmonary Medicine, Cleveland Clinic, 9500 Euclid Avenue/M2-141, Cleveland, Ohio 44195, USA.
Jaime H CheahBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, USA.
Paul A ClemonsBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, USA.
Alykhan ShamjiBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, USA.
Craig D PeacockDepartment of Translational Hematology Oncology Research, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.
Stuart L SchreiberBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, USA.ORCID http://orcid.org/0000-0003-1922-7558
Peter S HammermanBroad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, USA.
Mohamed E AbazeedDepartment of Translational Hematology Oncology Research, Cleveland Clinic, 9500 Euclid Avenue/R40, Cleveland, Ohio 44195, USA.

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
Knowledge-based Gene Expression Analysis for Biomedical and Cancer ResearchR01CA121941 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MESIROV, JILL P. · 2006 to 2016
$5.1M
Cancer dependencies associated with genomic alterations and targeted by small molU01CA176152 · NCI · BROAD INSTITUTE, INC. · PI SCHREIBER, STUART L · 2013 to 2016
$4.4M
Molecular Signatures to Characterize the Oncogenic State of Individual TumorsR01CA154480 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAMAYO, PABLO · 2011 to 2015
$2.0M
Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung CancerK08CA163677 · NCI · DANA-FARBER CANCER INST · PI HAMMERMAN, PETER S · 2012 to 2016
$783k
Howard Hughes Medical InstituteNCATS NIH HHS KL2 TR000440NCI NIH HHS K08 CA163677NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA121941NCI NIH HHS R01 CA154480NCI NIH HHS U01 CA176152
6 · The paper itself

Abstract

Radiotherapy is not currently informed by the genetic composition of an individual patient's tumour. To identify genetic features regulating survival after DNA damage, here we conduct large-scale profiling of cellular survival after exposure to radiation in a diverse collection of 533 genetically annotated human tumour cell lines. We show that sensitivity to radiation is characterized by significant variation across and within lineages. We combine results from our platform with genomic features to identify parameters that predict radiation sensitivity. We identify somatic copy number alterations, gene mutations and the basal expression of individual genes and gene sets that correlate with the radiation survival, revealing new insights into the genetic basis of tumour cellular response to DNA damage. These results demonstrate the diversity of tumour cellular response to ionizing radiation and establish multiple lines of evidence that new genetic features regulating cellular response after DNA damage can be identified.

Indexed as

DNA DamageCell Line, TumorCell SurvivalDNA Copy Number VariationsGene Expression Regulation, NeoplasticHumansNeoplasmsRadiation, IonizingRadiation Tolerance

Identifiers

PMID27109210
PMCPMC4848553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.